Agency Information Collection Activities: Proposed Collection: Public Comment Request Environmental Information and Documentation, OMB No. 0915-0324-Extension, 11450-11451 [2022-04267]
Download as PDF
<![CDATA[
11450
Federal Register / Vol. 87, No. 40 / Tuesday, March 1, 2022 / Notices
(CCDBG Act), as amended, CCDBG Act
of 2014 (Pub. L. 113–186), and 42 U.S.C.
9858. The Plan, submitted on the ACF–
118A, is required triennially, and
remains in effect for 3 years. The Plan
provides ACF and the public with a
description of and assurance about the
tribes’ child care programs. These Plans
are the applications for CCDF funds.
The Office of Child Care has given
thoughtful consideration of any
comments received on the Plan Preprint
document and revised the document in
line with comments. Additionally,
based on responses from Tribes and the
current context of managing the COVID–
19 Pandemic, OCC will postpone
modernizing the allocation size
thresholds. Requirements for this Tribal
CCDF Plan submission will continue to
be based on FY 2016 allocations.
Consistent with the statute and
regulations, ACF requests revision of the
ACF–118A with minor modifications.
This 30-day second Public Comment
Period provides an opportunity for the
public to submit comments to OMB.
Respondents: Tribal CCDF lead
agencies.
ANNUAL BURDEN ESTIMATES
Total
number of
respondents
Instrument
ACF–118A Part I (for all tribes) ...........................................
ACF–118A Part II (for medium and large tribes only) .........
Estimated Total Annual Burden
Hours: 11,448.
Authority: Pub. L. 113–186) and 42
U.S.C. 9858c.
[FR Doc. 2022–04199 Filed 2–28–22; 8:45 am]
BILLING CODE 4184–43–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Health Resources and Services
Administration
Agency Information Collection
Activities: Proposed Collection: Public
Comment Request Environmental
Information and Documentation, OMB
No. 0915–0324—Extension
Health Resources and Services
Administration (HRSA), Department of
Health and Human Services.
ACTION: Notice.
AGENCY:
In compliance with the
requirement for opportunity for public
comment on proposed data collection
projects of the Paperwork Reduction Act
of 1995, HRSA announces plans to
submit an Information Collection
Request (ICR), described below, to the
Office of Management and Budget
(OMB). Prior to submitting the ICR to
OMB, HRSA seeks comments from the
public regarding the burden estimate,
below, or any other aspect of the ICR.
DATES: Comments on this ICR should be
received no later than March 31, 2022.
jspears on DSK121TN23PROD with NOTICES1
VerDate Sep<11>2014
19:01 Feb 28, 2022
Jkt 256001
265
106
PO 00000
Frm 00056
Fmt 4703
Sfmt 4703
Average
burden hours
per response
1
1
Written comments and
recommendations for the proposed
information collection should be sent
within 30 days of publication of this
notice to www.reginfo.gov/public/do/
PRAMain. Find this particular
information collection by selecting
‘‘Currently under Review—Open for
Public Comments’’ or by using the
search function.
FOR FURTHER INFORMATION CONTACT: To
request more information on the
proposed project or to obtain a copy of
the data collection plans and draft
instruments, email paperwork@hrsa.gov
or call Samantha Miller, the acting
HRSA Information Collection Clearance
Officer at (301) 443–9094.
SUPPLEMENTARY INFORMATION: When
submitting comments or requesting
information, please include the
information collection request title for
reference.
Information Collection Request Title:
Environmental Information and
Documentation (EID) OMB No. 0915–
0324—Extension.
Abstract: HRSA is requesting
extension of the approval for the EID
checklist which consists of information
that the agency is required to obtain to
comply with the National
Environmental Policy Act of 1969
(NEPA). NEPA establishes the federal
government’s national policy for
protection of the environment. HRSA
has developed the EID for applicants of
funding that would potentially impact
the environment and to ensure that their
decision-making processes are
consistent with NEPA.
ADDRESSES:
Mary B. Jones,
ACF/OPRE Certifying Officer.
SUMMARY:
Total
number of
responses per
respondent
120
24
Total
burden hours
31,800
2,544
Annual
burden hours
10,600
848
A 60-day notice published in the
Federal Register, 86 FR 69655
(December, 8, 2021). There were no
public comments.
Need and Proposed Use of the
Information: Applicants must provide
information and assurance of
compliance with NEPA on the EID
checklist. This information is reviewed
in the Pre-Award stage (and/or prior to
the implementation of the project). The
information is reviewed in the PostAward stage for project changes and the
information is reviewed before the
implementation of the project changes.
Likely Respondents: HRSA applicants
applying for federal loan guarantees,
federal construction grants, and
cooperative agreements.
Burden Statement: Burden in this
context means the time expended by
persons to generate, maintain, retain,
disclose, or provide the information
requested. This includes the time
needed to review instructions; to
develop, acquire, install, and utilize
technology and systems for the purpose
of collecting, validating and verifying
information, processing and
maintaining information, and disclosing
and providing information; to train
personnel and to be able to respond to
a collection of information; to search
data sources; to complete and review
the collection of information; and to
transmit or otherwise disclose the
information. The total annual burden
hours estimated for this ICR are
summarized in the table below.
E:\FR\FM\01MRN1.SGM
01MRN1
11451
Federal Register / Vol. 87, No. 40 / Tuesday, March 1, 2022 / Notices
TOTAL ESTIMATED ANNUALIZED BURDEN HOURS
Number of
respondents
Form name
Average
burden per
response
(in hours)
Total
responses
Total burden
hours
NEPA EID Checklist ............................................................
1,500
1
1,500
1
1,500
Total ..............................................................................
1,500
........................
1,500
........................
1,500
HRSA specifically requests comments
on (1) the necessity and utility of the
proposed information collection for the
proper performance of the agency’s
functions, (2) the accuracy of the
estimated burden, (3) ways to enhance
the quality, utility, and clarity of the
information to be collected, and (4) the
use of automated collection techniques
or other forms of information
technology to minimize the information
collection burden.
Maria G. Button,
Director, Executive Secretariat.
[FR Doc. 2022–04267 Filed 2–28–22; 8:45 am]
BILLING CODE 4165–15–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
Prospective Grant of an Exclusive
Patent License: Development and
Commercialization of Chimeric Antigen
Receptor T-Cell Therapies (CAR–T)
That are Specific to CD22 and Other BCell Antigens for the Treatment of BCell Malignancies
AGENCY:
National Institutes of Health,
HHS.
ACTION:
Notice.
The National Cancer Institute,
an institute of the National Institutes of
Health, Department of Health and
Human Services, is contemplating the
grant of an Exclusive Patent License to
practice the inventions embodied in the
Patents and Patent Applications listed
in the Supplementary Information
section of this Notice to Syncopation
Life Sciences Inc., (‘‘Syncopation’’),
located in Palo Alto, California.
DATES: Only written comments and/or
complete applications for a license
which are received by the National
Cancer Institute’s Technology Transfer
Center on or before March 16, 2022 will
be considered.
ADDRESSES: Requests for copies of the
patent applications, inquiries, and
comments relating to the contemplated
Exclusive Patent License should be
directed to: Jim Knabb, Senior
SUMMARY:
jspears on DSK121TN23PROD with NOTICES1
Number of
responses per
respondent
VerDate Sep<11>2014
19:01 Feb 28, 2022
Jkt 256001
Technology Transfer Manager, at
Telephone: (240)–276–7856; or at email:
jim.knabb@nih.gov.
SUPPLEMENTARY INFORMATION:
Intellectual Property
E–080–2012–0: Human Monoclonal
Antibodies Specific for CD22
1. US Provisional Patent Application
61/042,329, filed April 4, 2008 (E–080–
2008–0–US–01);
2. International Patent Application
PCT/US2009/039,080, Filed April 1,
2009 (E–080–2008/0–PCT–02);
3. US Patent Application: 12/934,214,
filed September 23, 2010 (E–080–2008–
0–US–03);
4. US Patent Application 13/959,061,
filed August 5, 2015 (E–080–2008–0–
US–04);
5. US Patent Application 15/012,023,
filed February 1, 2016 (E–080–2008–0–
US–05);
6. US Patent Application 15/424,238,
filed February 3, 2017 (E–080–2008–0–
US–06).
E–291–2012–0: M971 Chimeric Antigen
Receptors
1. US Provisional Patent Application
61/717,960, filed October 24, 2012 (E–
291–2012–0–US–01);
2. International Patent Application
PCT/US2013/060332, filed September
18, 2013 (E–291–2012–0–PCT–02);
3. Australia Application No:
2019235926, filed September 2, 2020
(E–291–2012–0–AU–03);
4. Brazil Patent Application
BR112015009003–6, filed April 22, 2015
(E–291–2012–0–BR–04);
5. Canada Application No: 2889055,
filed September 18, 2013 (E–291–2012–
0–CA–05);
6. China Application No:
201380061387.5, filed May 25, 2015 (E–
291–2012–0–CN–06);
7. European Patent Application No:
13773468.7, filed September 18, 2013
(E–291–2012–0–EP–07);
8. India Patent Application No: 2344/
CHENP/2015, filed September 18, 2013
(E–291–2012–0–IN–08);
9. Japan Application No: 539602/
2015, filed April 24, 2015 (E–291–2012–
0–JP–09);
PO 00000
Frm 00057
Fmt 4703
Sfmt 4703
10. Russia Patent Application:
2015117237, filed May 7, 2015 (E–291–
2012–0–RU–10);
11. US Patent Application: 14/
437,889, filed April 23, 2015 (E–291–
2012–0–US–11);
12. Hong Kong Patent Application:
16101891.0, filed February 19, 2016 (E–
291–2012–0–HK–12);
13. Russia Patent Application:
2018116582, filed May 4, 2018 (E–291–
2012–0–RU–13);
14. Japan Patent Application: 2018–
088908, filed May 2, 2018, (E–291–
2012–0–JP–14);
15. Australia Patent Application:
2018204257, filed June 14, 2018 (E–
291–2012–0–AU–16);
16. US Patent Application: 16/
107,271, filed August 21, 2018 (E–291–
2012–0–US–17);
17. Germany Patent Application:
13773468.7, filed April 22, 2015 (E–
291–2012–0–DE–18);
18. Spain Patent Application:
13773468.7, filed April 22, 2015 (E–
291–2012–0–ES–19);
19. France Patent Application:
13773468.7, filed April 22, 2015 (E–
291–2012–0–FR–20);
20. Great Britain Patent Application:
13773468.7, filed April 22, 2015 (E–
291–2012–0–GB–21);
21. Italy Patent Application:
13773468.7, filed April 22, 2015 (E–
291–2012–0–IT–22);
22. China Patent Application:
201910500128.7, filed June 11, 2019 (E–
291–2012–0–CN–23);
23. US Patent Application: 16/
869,792, filed May 8, 2020 (E–291–
2012–0–US–24).
E–017–2017–0: CD19/CD22 Bicistronic
CAR Targeting Human B-Cell
Malignancies
1. US Provisional Patent Application
No.: 62/135,442, filed May 15, 2017 (E–
017–2017–0–US–01);
2. International Patent Application
PCT/US2018/032,809, filed May 15,
2018 (E–017–2017–0–PCT–02);
3. Australia Patent Application No.:
2018269194, filed October 28, 2019 (E–
017–2017–0–AU–03);
4. Canada Patent Application No:
3062433, filed May 15, 2018 (E–017–
2017–0–CA–04);
E:\FR\FM\01MRN1.SGM
01MRN1
]]>Agencies
[Federal Register Volume 87, Number 40 (Tuesday, March 1, 2022)]
[Notices]
[Pages 11450-11451]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2022-04267]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Health Resources and Services Administration
Agency Information Collection Activities: Proposed Collection:
Public Comment Request Environmental Information and Documentation, OMB
No. 0915-0324--Extension
AGENCY: Health Resources and Services Administration (HRSA), Department
of Health and Human Services.
ACTION: Notice.
-----------------------------------------------------------------------
SUMMARY: In compliance with the requirement for opportunity for public
comment on proposed data collection projects of the Paperwork Reduction
Act of 1995, HRSA announces plans to submit an Information Collection
Request (ICR), described below, to the Office of Management and Budget
(OMB). Prior to submitting the ICR to OMB, HRSA seeks comments from the
public regarding the burden estimate, below, or any other aspect of the
ICR.
DATES: Comments on this ICR should be received no later than March 31,
2022.
ADDRESSES: Written comments and recommendations for the proposed
information collection should be sent within 30 days of publication of
this notice to www.reginfo.gov/public/do/PRAMain. Find this particular
information collection by selecting ``Currently under Review--Open for
Public Comments'' or by using the search function.
FOR FURTHER INFORMATION CONTACT: To request more information on the
proposed project or to obtain a copy of the data collection plans and
draft instruments, email [email protected] or call Samantha Miller,
the acting HRSA Information Collection Clearance Officer at (301) 443-
9094.
SUPPLEMENTARY INFORMATION: When submitting comments or requesting
information, please include the information collection request title
for reference.
Information Collection Request Title: Environmental Information and
Documentation (EID) OMB No. 0915-0324--Extension.
Abstract: HRSA is requesting extension of the approval for the EID
checklist which consists of information that the agency is required to
obtain to comply with the National Environmental Policy Act of 1969
(NEPA). NEPA establishes the federal government's national policy for
protection of the environment. HRSA has developed the EID for
applicants of funding that would potentially impact the environment and
to ensure that their decision-making processes are consistent with
NEPA.
A 60-day notice published in the Federal Register, 86 FR 69655
(December, 8, 2021). There were no public comments.
Need and Proposed Use of the Information: Applicants must provide
information and assurance of compliance with NEPA on the EID checklist.
This information is reviewed in the Pre-Award stage (and/or prior to
the implementation of the project). The information is reviewed in the
Post-Award stage for project changes and the information is reviewed
before the implementation of the project changes.
Likely Respondents: HRSA applicants applying for federal loan
guarantees, federal construction grants, and cooperative agreements.
Burden Statement: Burden in this context means the time expended by
persons to generate, maintain, retain, disclose, or provide the
information requested. This includes the time needed to review
instructions; to develop, acquire, install, and utilize technology and
systems for the purpose of collecting, validating and verifying
information, processing and maintaining information, and disclosing and
providing information; to train personnel and to be able to respond to
a collection of information; to search data sources; to complete and
review the collection of information; and to transmit or otherwise
disclose the information. The total annual burden hours estimated for
this ICR are summarized in the table below.
[[Page 11451]]
Total Estimated Annualized Burden Hours
----------------------------------------------------------------------------------------------------------------
Number of Average burden
Form name Number of responses per Total per response Total burden
respondents respondent responses (in hours) hours
----------------------------------------------------------------------------------------------------------------
NEPA EID Checklist.............. 1,500 1 1,500 1 1,500
-------------------------------------------------------------------------------
Total....................... 1,500 .............. 1,500 .............. 1,500
----------------------------------------------------------------------------------------------------------------
HRSA specifically requests comments on (1) the necessity and
utility of the proposed information collection for the proper
performance of the agency's functions, (2) the accuracy of the
estimated burden, (3) ways to enhance the quality, utility, and clarity
of the information to be collected, and (4) the use of automated
collection techniques or other forms of information technology to
minimize the information collection burden.
Maria G. Button,
Director, Executive Secretariat.
[FR Doc. 2022-04267 Filed 2-28-22; 8:45 am]
BILLING CODE 4165-15-P
